Sandra D. Bohling

Also affiliated with Seattle Children's Hospital, University of Washington Applied Physics Laboratory

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “CRLF2 -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy”.

CRLF2 -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009499

N/A

0DataRank · unranked

8 citations

Samantha Scanlon, Hao‐Wei Wang, Constance M. Yuan, Alyssa Doverte, Jake Wellek +17 more

Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement

HemaSphere(2025)10.1002/hem3.70247

N/A

0DataRank · unranked

6 citations

Sandra D. Bohling, Kara L. Davis, Aimee C. Talleur, Kevin O. McNerney, Swati Naik +12 more